A carregar...
Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma
The majority of patients with Hodgkin lymphoma are cured with frontline therapy; however, 10% to 15% with early-stage disease and 20% to 30% with advanced stage require second-line therapy that includes a potentially curative transplant, of which an additional 50% to 55% are cured. Those with multip...
Na minha lista:
| Publicado no: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142462/ https://ncbi.nlm.nih.gov/pubmed/27913499 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|